放射性碘
重组DNA
甲状腺癌
医学
甲状腺
碘
癌症
内科学
内分泌学
核医学
肿瘤科
放射化学
癌症研究
化学
生物化学
基因
有机化学
作者
Hui Tan,Yushen Gu,Yan Xiu,Xingmin Han,Qiang Wen,Zhongwei Lv,Wei Fan,Sijin Li,Jian Tan,Feng Wang,Wei Fu,Yifan Zhang,Jun Xin,Wei Ouyang,Xuemei Wang,Bin Liu,Yue Chen,Xuegong Liu,Mo Yi,Quan‐Yong Luo
出处
期刊：JAMA network open
[American Medical Association]
日期：2024-11-07
卷期号：7 (11): e2443407-e2443407
标识
DOI：10.1001/jamanetworkopen.2024.43407
摘要
Radioactive iodine (131I or RAI) therapy has long been the standard of care for most patients with differentiated thyroid cancer (DTC) after primary surgery. However, no multicenter prospective studies have identified the optimal administered activity and stimulation method for RAI therapy in patients with intermediate-risk DTC.
科研通智能强力驱动
Strongly Powered by AbleSci AI
SYLH
昏睡的蟠桃
无语的安白
cdercder
平常的毛豆
coolkid
jenningseastera
Kirito
Ivy
pluto
可千万不要躺平呀
HEIKU
从容芮
OCDer
hjyylab
彭于彦祖
孙燕
Reborn
典雅的俊驰
8R60d8
皖公网安备34019202002308
